Log in or Sign up for Free to view tailored content for your specialty!
Hepatology News
VIDEO: Expert discusses HCV treatment during pregnancy, mother-to-child transmission
BOSTON — In this video, Nancy S. Reau, MD, FAASLD, AGAF, reviews three abstracts presented at The Liver Meeting related to pregnancy and pediatric treatments for hepatitis C virus infection.
VIDEO: Unmet need in ACLF presents ‘very large opportunity’ for new technology
In this Healio video exclusive, Dean Hum, PhD, chief scientific officer at Genfit, outlines five ongoing programs in the company’s acute-on-chronic liver failure development pipeline, which recently were presented at The Liver Meeting.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Race, biomarkers among risk factors for HCC in spontaneously cleared HCV
BOSTON — According to an abstract at The Liver Meeting, patients of Hispanic ethnicity who had elevated liver enzymes at baseline remained at increased risk for hepatocellular carcinoma, despite spontaneously clearing hepatitis C virus.
ACG publishes new guideline for management of alcohol-associated liver disease
A new clinical guideline published in the American Journal of Gastroenterology underscored the need to overcome barriers to alcohol use disorder treatment and expand multidisciplinary care for patients with alcohol-associated liver disease.
‘S’ or ‘C’ corporation: Maximize tax treatment of your practice
When choosing a structure for a practice, you are making two choices: what legal structure to choose and which tax treatment to select.
Strategize future finances with Healio’s Residency to Retirement
The Residency to Retirement resource center offers insightful and innovative strategies to help physicians reduce taxes, protect assets, invest wisely and build wealth during all phases of their careers.
Developments in hepatitis care: New CDC recommendations and more
As viral hepatitis continues to be a major health concern in the infectious disease field, recent research has highlighted the importance of testing and treatment.
Directly observed therapy for HCV successful even at extended intervals among PWIDs
BOSTON — Use of directly observed therapy was successful even at extended intervals when treating hepatitis C virus infection among people who inject drugs, according to research presented at The Liver Meeting.
Sofosbuvir/velpatasvir with ribavirin improves liver, renal function in chronic HCV
BOSTON — A regimen of sofosbuvir/velpatasvir with ribavirin was effective among patients with refractory chronic hepatitis C virus with liver cirrhosis and chronic kidney disease, according to data presented at The Liver Meeting.
National virtual HCV program expands access to care for children, adolescents in the UK
BOSTON — A virtual treatment program that coordinates care with local providers improved therapy for children and adolescents with hepatitis C virus in the United Kingdom, according to a presentation at The Liver Meeting.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read